Fidson announces appointment of three directors
By Kayode Tokede
Fidson Healthcare Plc has appointed three new directors.
According to a notice by the pharmaceutical firm to the Nigerian Stock Exchange, the directors were appointed at a board meeting.
The three directors namely, Dr Vincent Ahonkhai, Mr. Ekwunife Okoli and Mr. Ola Ijimakin appointments are effective January 1, 2021.
Ahonkhai is an expert in Global Health and biopharmaceutical Research and Development.
He is currently an independent consultant and principal at Gwynedd Consultancy, LLC in Pennsylvania, the USA from where he consults for organisations such as Bill & Melinda Gates Foundation amongst others.
He will bring to the board, experience in research and development, which is crucial to the development of the pharmaceutical industry, the company said. He was appointed an independent non-executive director.
Okoli is versatile in the field of sales and marketing, having worked for many years in the FMCG industry. He was an Executive Director, Marketing at Diageo Plc. He was also managing director of the same company in Cameroun and Ghana and managing director for Africa and Regional Markets.
According to the statement, Okoli is an experienced non-executive director who sits on the board of Cornerstone Insurance Plc. He is married to Mrs Unoma Okoli and blessed with four children. He is expected to enrich the expertise in the sales and marketing department. He was appointed an independent non-executive director.
ljimakin joined the organisation in July 2002 as regional manager in the North-eastern 80. He graduated from the University of Jos where he was awarded a Bachelor of Pharmacy degree.
He won the prize for the best graduating student in pharmacy among other prestigious awards. He holds a Master of Business Administration degree from the Business School Netherlands, Buren (2014) where he finished with a distinction.
He is said to be a seasoned professional who has grown through the ranks over the years. He served as Group Marketing Manager from May 2005 to December 2006; General Manager, Marketing from April 2011 to May 2016 and General Manager, Sales and Marketing from May 2016 till date.
Over the years, as GM Sales & Marketing, his drive for results reflected in more than 100 per cent revenue sales growth from N7.6bn to over N17bn.
ljimakin is vastly experienced, having served in large corporations both at home and abroad. He is a fellow of the Pharmaceutical Society of Nigeria.
